Release Date: 05.07.2015 | Location: All Metro Atlanta | Organization: Andrew Young Foundation and Morehouse School of Medicine
May 13th Press Conference Announcing Initial Success of Plant-based Ebola Treatment
Presented by the Andrew Young Foundation, Morehouse School of Medicine and PROMETRA at GPB
INDIGENOUS AFRICAN PLANT-BASED EXTRACTS PROVIDE
GROUNDBREAKING EFFICACY AGAINST EBOLA VIRUS
U.S. Army Laboratory Results Demonstrate Preliminary Success Against Live Ebola Cells
The Andrew J. Young Foundation (AJYF) in partnership with Morehouse School of Medicine (MSM) and PROMETRA International will announce the groundbreaking lab results of testing indigenous African plant-based extracts against the Ebola virus by the US Army Research Institute of Infectious Diseases (USAMRIID) in Fort Detrick, Maryland.
This research is a result of the continuing partnership between Morehouse School of Medicine, the Andrew J. Young Foundation and PROMETRA International with a Memorandum of Understanding (MOU) in place since 2010. This partnership was created to improve the health and wellbeing of Africa and the Diaspora.
Andrew J. Young Foundation
Ambassador Andrew Young, chair
Morehouse School of Medicine
Dr. Valerie Montgomery-Rice, president and dean;
Dr. Sandra Harris-Hooker, executive vice dean for research & academic affairs;
Dr. Michael Powell, associate professor, microbiology, biochemistry and immunology; director, translational technologies program
Dr. Erick V. A. Gbodossou, president
Wednesday, May 13, 2015
Georgia Public Broadcasting Building,Studio C
260 14th Street, NW
Atlanta, Georgia 30318
The press conference will be live-streamed via www.AfricasAnswer.com and followed by a roundtable discussion with the press conference partners and in-studio audience of stakeholders.
The Ebola epidemic continues to ravage Western Africa and remains a threat to the entire world. With 25,826 cases and 10,704 deaths already reported, national economies demolished, agriculture shattered, children orphaned and education interrupted, the need for therapies is critical.
Contact Name: Kelley Jackson
Company: Andrew Young Foundation